Baker Bros. Advisors Lp - Net Worth and Insider Trading

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in IGM Biosciences Inc (IGMS). Other recent insider transactions involving IGM Biosciences Inc (IGMS) include a net sale of 94,462 shares made by Bruce Keyt , a net sale of 10,207 shares made by George Gauthier , and a net sale of 10,938 shares made by Misbah Tahir .

In summary, during the past 3 months, insiders sold 15,163 shares of IGM Biosciences Inc (IGMS) in total and bought 0 shares, with a net sale of 15,163 shares. During the past 18 months, 149,551 shares of IGM Biosciences Inc (IGMS) were sold and 173,672 shares were bought by its insiders, resulting in a net purchase of 24,121 shares.

IGM Biosciences Inc (IGMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made 3 insider transaction in Incyte Corp (INCY) with a net purchase of 2,510,403. Other recent insider transactions involving Incyte Corp (INCY) include a net sale of 30,111 shares made by Vijay K Iyengar , a net sale of 46,866 shares made by Barry P Flannelly , and a net sale of 2,787 shares made by Thomas Tray .

In summary, during the past 3 months, insiders sold 0 shares of Incyte Corp (INCY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 208,851 shares of Incyte Corp (INCY) were sold and 2,510,403 shares were bought by its insiders, resulting in a net purchase of 2,301,552 shares.

Incyte Corp (INCY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made 6 insider transaction in Kodiak Sciences Inc (KOD) with a net purchase of 2,629,186. Other recent insider transactions involving Kodiak Sciences Inc (KOD) include a net sale of 17,387 shares made by Jason Ehrlich , a net sale of 1,340,000 shares made by Victor Perlroth , and a net sale of 4,343 shares made by John A. Borgeson .

In summary, during the past 3 months, insiders sold 0 shares of Kodiak Sciences Inc (KOD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,361,730 shares of Kodiak Sciences Inc (KOD) were sold and 2,629,186 shares were bought by its insiders, resulting in a net purchase of 1,267,456 shares.

Kodiak Sciences Inc (KOD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Prelude Therapeutics Inc (PRLD). Other recent insider transactions involving Prelude Therapeutics Inc (PRLD) include a net purchase of 32,944 shares made by Krishna Vaddi , a net purchase of 25,000 shares made by Laurent Chardonnet , and a net purchase of 869,565 shares made by David P Bonita .

In summary, during the past 3 months, insiders sold 13,280 shares of Prelude Therapeutics Inc (PRLD) in total and bought 1,760,286 shares, with a net purchase of 1,747,006 shares. During the past 18 months, 42,031 shares of Prelude Therapeutics Inc (PRLD) were sold and 1,807,474 shares were bought by its insiders, resulting in a net purchase of 1,765,443 shares.

Prelude Therapeutics Inc (PRLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Kiniksa Pharmaceuticals Ltd (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals Ltd (KNSA) include a net sale of 28,357 shares made by John Paolini , and a net sale of 21,959 shares made by Barry D Quart .

In summary, during the past 3 months, insiders sold 0 shares of Kiniksa Pharmaceuticals Ltd (KNSA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 50,316 shares of Kiniksa Pharmaceuticals Ltd (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 50,316 shares.

Kiniksa Pharmaceuticals Ltd (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Atreca Inc (BCEL). Other recent insider transactions involving Atreca Inc (BCEL) include a net sale of 37,646 shares made by Tito Serafini , a net sale of 20,908 shares made by John A Orwin , and a net sale of 7,646 shares made by Herb Cross .

In summary, during the past 3 months, insiders sold 0 shares of Atreca Inc (BCEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 72,632 shares of Atreca Inc (BCEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 72,632 shares.

Atreca Inc (BCEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in BeiGene Ltd (BGNE). Other recent insider transactions involving BeiGene Ltd (BGNE) include a net sale of 98,695 shares made by Xiaodong Wang , a net sale of 109,928 shares made by John Oyler , and a net sale of 18,723 shares made by Xiaobin Wu .

In summary, during the past 3 months, insiders sold 74,635 shares of BeiGene Ltd (BGNE) in total and bought 0 shares, with a net sale of 74,635 shares. During the past 18 months, 232,954 shares of BeiGene Ltd (BGNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 232,954 shares.

BeiGene Ltd (BGNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made 1 insider transaction in ACADIA Pharmaceuticals Inc (ACAD) with a net purchase of 896,522. Other recent insider transactions involving ACADIA Pharmaceuticals Inc (ACAD) include a net sale of 40,076 shares made by Stephen Davis , a net sale of 19,723 shares made by Brendan Teehan , and a net sale of 6,015 shares made by Austin D. Kim .

In summary, during the past 3 months, insiders sold 60,326 shares of ACADIA Pharmaceuticals Inc (ACAD) in total and bought 896,522 shares, with a net purchase of 836,196 shares. During the past 18 months, 115,704 shares of ACADIA Pharmaceuticals Inc (ACAD) were sold and 896,522 shares were bought by its insiders, resulting in a net purchase of 780,818 shares.

ACADIA Pharmaceuticals Inc (ACAD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made 1 insider transaction in Seagen Inc (SGEN) with a net sale of 394,895. Other recent insider transactions involving Seagen Inc (SGEN) include a net sale of 98,465 shares made by Roger D Dansey , a net sale of 40,049 shares made by Jean I Liu , and a net sale of 165,391 shares made by Todd E Simpson .

In summary, during the past 3 months, insiders sold 226,723 shares of Seagen Inc (SGEN) in total and bought 0 shares, with a net sale of 226,723 shares. During the past 18 months, 997,657 shares of Seagen Inc (SGEN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 997,657 shares.

Seagen Inc (SGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Zymeworks Inc (ZYME). Other recent insider transactions involving Zymeworks Inc (ZYME) include a net purchase of 2,518,900 shares made by Ecor1 Capital, Llc , a net sale of 2,425 shares made by Neil Josephson , and a net sale of 5,956 shares made by Neil A Klompas .

In summary, during the past 3 months, insiders sold 2,977 shares of Zymeworks Inc (ZYME) in total and bought 200,000 shares, with a net purchase of 197,023 shares. During the past 18 months, 15,155 shares of Zymeworks Inc (ZYME) were sold and 2,554,381 shares were bought by its insiders, resulting in a net purchase of 2,539,226 shares.

Zymeworks Inc (ZYME)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Neoleukin Therapeutics Inc (NLTX). Other recent insider transactions involving Neoleukin Therapeutics Inc (NLTX) include a net sale of 23,687 shares made by Priti Patel , and a net sale of 4,971 shares made by Sean Michael Smith .

In summary, during the past 3 months, insiders sold 3,769 shares of Neoleukin Therapeutics Inc (NLTX) in total and bought 0 shares, with a net sale of 3,769 shares. During the past 18 months, 28,658 shares of Neoleukin Therapeutics Inc (NLTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 28,658 shares.

Neoleukin Therapeutics Inc (NLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Aceragen Inc (ACGN). Other recent insider transactions involving Aceragen Inc (ACGN) include a net sale of 264,324 shares made by Atul Chopra , and a net purchase of 10,000 shares made by John J. Kirby .

In summary, during the past 3 months, insiders sold 264,324 shares of Aceragen Inc (ACGN) in total and bought 0 shares, with a net sale of 264,324 shares. During the past 18 months, 264,324 shares of Aceragen Inc (ACGN) were sold and 10,000 shares were bought by its insiders, resulting in a net sale of 254,324 shares.

Aceragen Inc (ACGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in HOOKIPA Pharma Inc (HOOK). Other recent insider transactions involving HOOKIPA Pharma Inc (HOOK) include a net sale of 14,949 shares made by Igor Matushansky ,

In summary, during the past 3 months, insiders sold 0 shares of HOOKIPA Pharma Inc (HOOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 14,949 shares of HOOKIPA Pharma Inc (HOOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 14,949 shares.

HOOKIPA Pharma Inc (HOOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Invitae Corp (NVTA). Other recent insider transactions involving Invitae Corp (NVTA) include a net sale of 123,370 shares made by Kenneth D. Knight , a net sale of 109,860 shares made by Yafei Wen , and a net sale of 61,835 shares made by Robert L Nussbaum .

In summary, during the past 3 months, insiders sold 262,007 shares of Invitae Corp (NVTA) in total and bought 0 shares, with a net sale of 262,007 shares. During the past 18 months, 519,311 shares of Invitae Corp (NVTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 519,311 shares.

Invitae Corp (NVTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Bellicum Pharmaceuticals Inc (BLCM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bellicum Pharmaceuticals Inc (BLCM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Bellicum Pharmaceuticals Inc (BLCM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Mirati Therapeutics Inc (MRTX). Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 12,843 shares made by Jamie Christensen , a net sale of 135,831 shares made by Charles M Baum , and a net sale of 9,493 shares made by Benjamin Hickey .

In summary, during the past 3 months, insiders sold 619 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 619 shares. During the past 18 months, 192,619 shares of Mirati Therapeutics Inc (MRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 192,619 shares.

Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 11,893 shares made by Hunter C Smith , a net sale of 16,071 shares made by Pamela J. Cramer , and a net sale of 5,222 shares made by Yann Mazabraud .

In summary, during the past 3 months, insiders sold 912 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 912 shares. During the past 18 months, 43,765 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 43,765 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 595,673 shares made by Jon P Stonehouse , a net sale of 81,615 shares made by Yarlagadda S Babu , and a net sale of 10,125 shares made by Helen M. Thackray .

In summary, during the past 3 months, insiders sold 7,000 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 7,000 shares. During the past 18 months, 883,572 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 883,572 shares.

BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Intellia Therapeutics Inc (NTLA). Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 9,166 shares made by John M. Leonard , a net sale of 5,986 shares made by Laura Sepp-lorenzino , and a net sale of 3,625 shares made by David Lebwohl .

In summary, during the past 3 months, insiders sold 0 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 27,195 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 27,195 shares.

Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in XOMA Corp (XOMA). Other recent insider transactions involving XOMA Corp (XOMA) include a net purchase of 5,850 shares made by Bradley Sitko , a net purchase of 103,200 shares made by Biotechnology Value Fund L P , and a net sale of 78,450 shares made by James R Neal .

In summary, during the past 3 months, insiders sold 0 shares of XOMA Corp (XOMA) in total and bought 7,850 shares, with a net purchase of 7,850 shares. During the past 18 months, 94,950 shares of XOMA Corp (XOMA) were sold and 111,050 shares were bought by its insiders, resulting in a net purchase of 16,100 shares.

XOMA Corp (XOMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of XOMA Corp (XOMAO.PFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XOMA Corp (XOMAO.PFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

XOMA Corp (XOMAO.PFD)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Talis Biomedical Corp (TLIS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Talis Biomedical Corp (TLIS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Talis Biomedical Corp (TLIS)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of DBV Technologies SA (DBVT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DBV Technologies SA (DBVT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DBV Technologies SA (DBVT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made no insider transaction in Aeglea BioTherapeutics Inc (AGLE). Other recent insider transactions involving Aeglea BioTherapeutics Inc (AGLE) include a net purchase of 278,379 shares made by Anthony G. Quinn , a net purchase of 125,000 shares made by Jonathan Alspaugh , and a net purchase of 150,000 shares made by Armen Shanafelt .

In summary, during the past 3 months, insiders sold 0 shares of Aeglea BioTherapeutics Inc (AGLE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aeglea BioTherapeutics Inc (AGLE) were sold and 671,579 shares were bought by its insiders, resulting in a net purchase of 671,579 shares.

Aeglea BioTherapeutics Inc (AGLE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made 3 insider transaction in Entrada Therapeutics Inc (TRDA) with a net purchase of 161,400. Other recent insider transactions involving Entrada Therapeutics Inc (TRDA) include a net sale of 72,092 shares made by Dipal Doshi , a net sale of 32,956 shares made by Nathan J Dowden , and a net sale of 33,200 shares made by Nerissa Kreher .

In summary, during the past 3 months, insiders sold 10,053 shares of Entrada Therapeutics Inc (TRDA) in total and bought 0 shares, with a net sale of 10,053 shares. During the past 18 months, 166,993 shares of Entrada Therapeutics Inc (TRDA) were sold and 166,400 shares were bought by its insiders, resulting in a net sale of 593 shares.

Entrada Therapeutics Inc (TRDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Bros. Advisors Lp made 1 insider transaction in TScan Therapeutics Inc (TCRX) with a net purchase of 1,359,792. Other recent insider transactions involving TScan Therapeutics Inc (TCRX) include a net purchase of 21,000 shares made by Brian M. Silver , a net purchase of 25,000 shares made by David P Southwell ,

In summary, during the past 3 months, insiders sold 0 shares of TScan Therapeutics Inc (TCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TScan Therapeutics Inc (TCRX) were sold and 1,405,792 shares were bought by its insiders, resulting in a net purchase of 1,405,792 shares.

TScan Therapeutics Inc (TCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.